Ocular Therapeutix, Inc. (OCUL)
NASDAQ · Manufacturing · Pharmaceutical preparations
$9.65−$0.1700 (−1.73%) on the dayAs of the close; data may be delayed.
OCUL price, last 12 months
Key stats
- Previous close
- $9.82
- Open
- $9.84
- Day range
- $9.59 – $9.85
- 52-week range
- $6.23 – $16.44
- Volume
- 1.3M
- Avg volume (20 days)
- 2.2M
- Market cap
- $2.1B
Performance
1W−3.4%
1M−10.4%
3M−1.9%
6M+19.6%
YTD−20.5%
1Y−23.2%
vs S&P 500, 1Y−40.0 pts
Technicals and fundamentals
About Ocular Therapeutix, Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $2.1B